Related Experiment Video
Updated: Jan 29, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Analysis of Macrolide Resistance in Bordetella pertussis Isolated from Japanese Children in 2025 Using Test Kit and
Tomohiro Oishi1, Takashi Nakano2
1Department of Clinical Infectious Diseases, Kawasaki Medical School, 577, Matsushima, Kurashiki 701-0192, Okayama, Japan.
Abstract:
Background: Bordetella pertussis causes pertussis, a respiratory infection with whooping cough. Despite a high vaccine coverage, pertussis resurged post-COVID-19 pandemic. Meanwhile, isolates resistant to macrolides-the first-line therapy-have increased in several countries, including Japan. Culturing B. pertussis and detecting resistance are difficult; reports remain limited in Japan. Methods: From March to August 2025, we collected nasopharyngeal samples from children aged 0-15 years with suspected pertussis at six Japanese clinics. Pediatricians obtained swabs and tested them using gene-amplification kits (e.g., BioFire® SpotFire® in four clinics, LAMP Pertussis Detection® in two clinics). B. pertussis was confirmed by PCR; isolates were sequenced to identify macrolide-resistant mutations. Results: Samples were taken from 54 children, the number of boys and girls was 34 and 20, and their median age was 12 years old. Among 54 B. pertussis isolates, 43/52 (82.7%) sequenced strains harbored the A2047G mutation associated with macrolide resistance. Resistance rates at each clinic varied from 40% to 96%. Conclusions: These findings indicate a post-pandemic rise in macrolide-resistant B. pertussis in Japan. Ongoing resistance surveillance is essential, and repurposing residual clinical samples after routine testing is useful given culture and detection challenges.
Insights
Pertussis (whooping cough) is resurging in Japan post-pandemic, with most Bordetella pertussis isolates showing macrolide resistance. This highlights the urgent need for ongoing surveillance of pertussis and antibiotic resistance.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Pertussis, caused by Bordetella pertussis, is a significant respiratory illness.
- Vaccine coverage has not prevented a post-COVID-19 pandemic resurgence of pertussis.
- Increasing macrolide resistance in Bordetella pertussis isolates is a growing global concern, particularly in Japan.
Purpose of the Study:
- To investigate the prevalence of macrolide-resistant Bordetella pertussis in children in Japan.
- To assess the feasibility of using residual clinical samples for resistance detection.
Main Methods:
- Nasopharyngeal samples were collected from 54 children (aged 0-15) with suspected pertussis between March and August 2025.
- Bordetella pertussis was identified using PCR, and isolates were sequenced to detect macrolide resistance mutations.
- Gene-amplification kits were utilized for rapid detection in participating clinics.
Main Results:
- Of 54 Bordetella pertussis isolates, 43 out of 52 (82.7%) harbored the A2047G mutation conferring macrolide resistance.
- Reported macrolide resistance rates varied significantly across different clinics, ranging from 40% to 96%.
Conclusions:
- A significant increase in macrolide-resistant Bordetella pertussis strains has been observed in Japan following the pandemic.
- Continuous surveillance for antibiotic resistance in Bordetella pertussis is crucial.
- Repurposing residual clinical samples offers a viable solution for resistance monitoring due to challenges in culturing and detection.
More Related Videos
Related Concept Videos
Resistivity
Resistance
Cis-regulatory Sequences
Pedigree Analysis
Sequences
Equivalent Resistance

